OptimizeRx

OPRX · NASDAQ

$8.93+$0.19 (+2.17%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $8.74

Latest news

NewsAug 12, 4:10 PM ET
OptimizeRx Q2 Adj. EPS $0.16 Beats $0.12 Estimate, Sales $20.504M Beat $20.204M Estimate
Press releaseAug 12, 4:01 PM ETGlobe Newswire
OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
NewsMay 13, 1:06 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
NewsMay 12, 5:08 PM ET
OptimizeRx Reports Q1 2026 Results: Full Earnings Call Transcript
NewsMay 12, 5:06 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
NewsMay 12, 4:12 PM ET
OptimizeRx Q1 Adj. EPS $0.14 Beats $0.00 Estimate, Sales $19.844M Beat $18.353M Estimate
Press releaseMay 12, 4:01 PM ETGlobe Newswire
OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
NewsMay 12, 7:11 AM ET
Earnings Scheduled For May 12, 2026
Press releaseApr 16, 4:05 PM ETBusiness Wire
Myomo Appoints William J Febbo to its Board of Directors
NewsMar 18, 8:05 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
NewsMar 6, 1:09 PM ETVandana Singh
OptimizeRx Warns Of Volatility From 'Most Favored Nation' Pricing Uncertainty
NewsMar 6, 1:00 PM ET
Assessing OptimizeRx: Insights From 4 Financial Analysts
NewsMar 6, 12:05 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
NewsMar 5, 4:05 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
NewsNov 6, 4:06 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
NewsNov 6, 6:12 AM ET
Earnings Scheduled For November 6, 2025
Press releaseAug 19, 7:30 AM ETGlobe Newswire
OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth
NewsAug 8, 1:07 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
NewsAug 8, 8:08 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
NewsAug 7, 5:08 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
Press releaseJul 30, 12:00 PM ETBusiness Wire
Paynela Appoints Healthcare Technology Veteran William Febbo to Board of Directors
Press releaseJun 18, 3:00 AM ETBusiness Wire
Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions
NewsMay 20, 5:06 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
NewsMay 13, 7:11 AM ET
Market-Moving News for May 13th
NewsMay 13, 5:45 AM ETRishabh Mishra
US Stocks Likely To Open Lower After A Strong Rally: 'Lows Are Likely In And Better Times Are Coming,' Says Expert
NewsMay 12, 5:06 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
NewsMar 12, 1:07 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
NewsMar 12, 11:56 AM ETVandana Singh
OptimizeRx Clocks Double-Digit Revenue Growth In Q4, Forecasts Sales Of At Least $100 Million
NewsFeb 6, 1:00 PM ET
Where OptimizeRx Stands With Analysts
NewsDec 20, 1:00 PM ET
The Analyst Verdict: OptimizeRx In The Eyes Of 6 Experts
NewsNov 14, 4:10 PM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NewsNov 6, 11:34 AM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
NewsAug 12, 10:00 AM ET
A Closer Look at 5 Analyst Recommendations For OptimizeRx
Press releaseJul 23, 7:30 AM ETGlobe Newswire
OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

OptimizeRx Q2 Adj. EPS $0.16 Beats $0.12 Estimate, Sales $20.504M Beat $20.204M Estimate

OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance

12 Health Care Stocks Moving In Wednesday's Intraday Session

OptimizeRx Reports Q1 2026 Results: Full Earnings Call Transcript

12 Health Care Stocks Moving In Tuesday's After-Market Session

OptimizeRx Q1 Adj. EPS $0.14 Beats $0.00 Estimate, Sales $19.844M Beat $18.353M Estimate

OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance

Earnings Scheduled For May 12, 2026

Myomo Appoints William J Febbo to its Board of Directors

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

OptimizeRx Warns Of Volatility From 'Most Favored Nation' Pricing Uncertainty

Assessing OptimizeRx: Insights From 4 Financial Analysts

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Thursday's After-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

Earnings Scheduled For November 6, 2025

OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

Paynela Appoints Healthcare Technology Veteran William Febbo to Board of Directors

Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions

12 Health Care Stocks Moving In Tuesday's After-Market Session

Market-Moving News for May 13th

US Stocks Likely To Open Lower After A Strong Rally: 'Lows Are Likely In And Better Times Are Coming,' Says Expert

12 Health Care Stocks Moving In Monday's After-Market Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

OptimizeRx Clocks Double-Digit Revenue Growth In Q4, Forecasts Sales Of At Least $100 Million

Where OptimizeRx Stands With Analysts

The Analyst Verdict: OptimizeRx In The Eyes Of 6 Experts

12 Health Care Stocks Moving In Thursday's Pre-Market Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

A Closer Look at 5 Analyst Recommendations For OptimizeRx

OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation